State program provides retirement fund for small-business employees – The Journal

Employers with five or more staff members who will automatically enroll in 2023 Businesses with five…

IARFC Releases the 2022 Fall Edition of its Journal of Personal Finance

Personal Finance Magazine My benefit in reading this academic work is that I think outside the…

New Mayo journal promises to be part of ‘disruptive transformation’ in medicine – Post Bulletin

ROCHESTER, MINNESOTA – The Mayo Clinic continued this week to signal its belief that the future…

Discover How Web3, NFTs & the Metaverse Fit in With Fashion – Sourcing Journal

The Council of Fashion Designers of America (CFDA) recently announced that it is celebrating its upcoming…

StartUp Mendocino 2023 accepting applicants – The Ukiah Daily Journal

The West Business Development Center (West Center) is accepting applications for StartUp Mendocino 2023. The free…

British Journal of Sports Medicine retracts further 9 articles authored by former editor in chief

That British Journal of Sports Medicine has 9 other non-research articles written by former editor-in-chief Dr.…

Whole-genome analysis of human papillomavirus 67 isolated from Japanese women with cervical lesions | Virology Journal

Schiffman M, Doorbar J, Wentzensen N, de Sanjose S, Fakhry C, Monk BJ, Stanley MA, Franceschi…

Hackensack Meridian Health Doctor, Bioethicist Publishes Surgery Decision-making Piece in New England Journal of Medicine

Newswise – OCTOBER 6, 2022, Nutley, NJ – A Hackensack meridian Health Physicians and bioethicists examine…

Monos Raises $30 Million – Digital Journal

Vancouver, British Columbia – (Newsfile Corp. – September 30, 2022) – Monos.com, a Vancouver-based travel and…

Eureka Therapeutics Announces New England Journal of Medicine Publication of Clinical Study Demonstrating GPRC5D as an Active Target for the Treatment of Multiple Myeloma | News

EMERYVILLE, Calif.–(BUSINESS WIRE)–Aug. September 2022– Eureka Therapeutics, Inc., a clinical-stage biotechnology company developing novel T-cell therapies…